Absence of p53-Dependent Apoptosis Combined With Nonhomologous End-Joining Deficiency Leads to a Severe Diabetic Phenotype in Mice
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Regulation of pancreatic β-cell mass is essential to preserve sufficient insulin levels for the maintenance of glucose homeostasis. Previously, we reported that DNA double-strand breaks (DSBs) resulting from nonhomologous end-joining (NHEJ) deficiency induce apoptosis and, when combined with p53 deficiency, progressed rapidly into lymphomagenesis in mice. Combination of NHEJ deficiency with a hypomorphic mutation, p53R172P, leads to the abrogation of apoptosis, upregulation of p21, and senescence in precursor lymphocytes. This was sufficient to prevent tumorigenesis. However, these mutant mice succumb to severe diabetes and die at an early age. The aim of this study was to determine the pathogenesis of diabetes in these mutant mice. RESEARCH DESIGN AND METHODS: We analyzed the morphology of the pancreatic islets and the function, proliferation rate, and senescence of β-cells. We also profiled DNA damage and p53 and p21 expression in the pancreas. RESULTS: NHEJ-p53R172P mutant mice succumb to diabetes at 3–5 months of age. These mice show a progressive decrease in pancreatic islet mass that is independent of apoptosis and innate immunity. We observed an accumulation of DNA damage, accompanied with increased levels of p53 and p21, a significant decrease in β-cell proliferation, and cellular senescence in the mutant pancreatic islets. CONCLUSIONS: Combined DSBs with an absence of p53-dependent apoptosis activate p53-dependent senescence, which leads to a diminished β-cell self-replication, massive depletion of the pancreatic islets, and severe diabetes. This is a model that connects impaired DNA repair and accumulative DNA damage, a common phenotype in aging individuals, to the onset of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In mice lacking p53-dependent apoptosis, the burden of senescent cells increases rapidly and is associated with dysfunction of pancreatic β-cells, causing an overt diabetic phenotype in 3–4 months (65).”
From Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity (2015) · cites this paper as [65]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation
Dor, Y., Brown, J., Martinez, O. I., & Melton, D. A. (2004) · Nature · doi:10.1038/nature02520 · Cited by 2,219
Living on a break: cellular senescence as a DNA-damage response
d'Adda di Fagagna, F. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2440 · Cited by 1,170 · cited 1×
“These properties may cause aging-related diseases (13).”
p16INK4a induces an age-dependent decline in islet regenerative potential
Krishnamurthy, J., Ramsey, M. R., Ligon, K. L., Torrice, C., Koh, A., Bonner-Weir, S., & Sharpless, N. E. (2006) · Nature · doi:10.1038/nature05092 · Cited by 1,003 · cited 2×
“Conversely, p16 (36), p18, or p27 (38) deficiency results in pancreatic islet hyperplasia.”
BackgroundRepair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining
Mahaney, B. L., Meek, K., & Lees-Miller, S. P. (2009) · Biochemical Journal · doi:10.1042/bj20080413 · Cited by 717 · cited 1×
“Classic nonhomologous end-joining (NHEJ) is one of the two major pathways for the repair of DNA double-strand breaks (DSBs) (1).”
BackgroundRane, S. G., Dubus, P., Mettus, R. V., Galbreath, E. J., Boden, G., Reddy, E. P., & Barbacid, M. (1999) · Nature Genetics · doi:10.1038/8751 · Cited by 700 · cited 3×
“Such examples are CDK4-deficient (32,33) or Cyclin D2–deficient (18,34) mice; both models have a progressive reduction of -cell number and gross onset of diabetes with features of hyperglycemia and glucose intolerance.”
BackgroundA critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis
Gao, Y., Sun, Y., Frank, K. M., Dikkes, P., Fujiwara, Y., Seidl, K. J., Sekiguchi, J. M., Rathbun, G. A., Swat, W., Wang, J., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81714-6 · Cited by 688
Self-citationLate embryonic lethality and impaired V (D)J recombination in mice lacking DNA ligase IV
Frank, K. M., Sekiguchi, J. M., Seidl, K. J., Swat, W., Rathbun, G. A., Cheng, H.-L., Davidson, L., Kangaloo, L., & Alt, F. W. (1998) · Nature · doi:10.1038/24172 · Cited by 594
Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development
Gao, Y., Ferguson, D. O., Xie, W., Manis, J. P., Sekiguchi, J., Frank, K. M., Chaudhuri, J., Horner, J., DePinho, R. A., & Alt, F. W. (2000) · Nature · doi:10.1038/35009138 · Cited by 580 · cited 1×
“The embryonic lethality is rescued by p53 deficiency (6,9).”
BackgroundGrowth and Regeneration of Adult β Cells Does Not Involve Specialized Progenitors
Teta, M., Rankin, M. M., Long, S. Y., Stein, G. M., & Kushner, J. A. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.04.011 · Cited by 551
Oxidative stress: the vulnerable β-cell
Lenzen, S. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360343 · Cited by 531 · cited 2×
“Due to the high energy consumption, pancreatic -cells are particularly susceptible to DNA damage caused by intrinsic metabolic agents such as reactive oxygen species (29).”
Backgroundβ cell replication is the primary mechanism for maintaining postnatal β cell mass
Georgia, S. K., & Bhushan, A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422098 · Cited by 506
Frank, K. M., Sharpless, N. E., Gao, Y., Sekiguchi, J. M., Ferguson, D. O., Zhu, C., Manis, J. P., Horner, J., DePinho, R. A., & Alt, F. W. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80264-6 · Cited by 497 · cited 1×
“The embryonic lethality is rescued by p53 deficiency (6,9).”
BackgroundSelf-citationZhu, C., Mills, K. D., Ferguson, D. O., Lee, C., Manis, J., Fleming, J., Gao, Y., Morton, C. C., & Alt, F. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00770-5 · Cited by 421
Self-citationApoptosis Participates in the Remodeling of the Endocrine Pancreas in the Neonatal Rat
Scaglia, L. (1997) · Endocrinology · doi:10.1210/en.138.4.1736 · Cited by 418 · cited 1×
“Many diabetic models with resulting -cell loss are due to an increase in isletspecific apoptosis (26,27).”
BackgroundTargeted Disruption of CDK4 Delays Cell Cycle Entry with Enhanced p27 Kip1 Activity
Tsutsui, T., Hesabi, B., Moons, D. S., Pandolfi, P. P., Hansel, K. S., Koff, A., & Kiyokawa, H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.7011 · Cited by 395 · cited 2×
“Such examples are CDK4-deficient (32,33) or Cyclin D2–deficient (18,34) mice; both models have a progressive reduction of -cell number and gross onset of diabetes with features of hyperglycemia and glucose intolerance.”
BackgroundCyclins D2 and D1 Are Essential for Postnatal Pancreatic β-Cell Growth
Kushner, J. A., Ciemerych, M. A., Sicinska, E., Wartschow, L. M., Teta, M., Long, S. Y., Sicinski, P., & White, M. F. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.9.3752-3762.2005 · Cited by 334
Liu, G., Parant, J. M., Lang, G., Chau, P., Chavez-Reyes, A., El-Naggar, A. K., Multani, A., Chang, S., & Lozano, G. (2004) · Nature Genetics · doi:10.1038/ng1282 · Cited by 325 · cited 1×
“Interestingly, a hypomorphic mutant p53, p53 (referred to as p53), which is defective in apoptosis but not in cell cycle arrest (11), not only rescues embryonic lethality but also entirely eliminates lymphomagenesis in the Lig4 / (12).”
BackgroundSone, H., & Kagawa, Y. (2005) · Diabetologia · doi:10.1007/s00125-004-1605-2 · Cited by 286 · cited 1×
“Several reports have revealed that senescence induced by telomeric shortening or other means has been linked to limiting -cell proliferation and diabetes (21,22).”
BackgroundDEFRONZO, R. (1997) · The Netherlands Journal of Medicine · doi:10.1016/s0300-2977(97)00012-0 · Cited by 277 · cited 1×
“Type 2 diabetes results from a progressive islet dysfunction leading to defective -cell secretion and insulin resistance (24,25).”
BackgroundMolecular regulation of pancreatic β-cell mass development, maintenance, and expansion
Ackermann, A. M., & Gannon, M. (2007) · Journal of Molecular Endocrinology · doi:10.1677/jme-06-0053 · Cited by 262 · cited 2×
“highly regulated by intrinsic genetic programs, extrinsic growth factors, and hormone levels in response to various challenges and physiological demands (14,15).”
BackgroundWei, Y.-F., Robins, P., Carter, K., Caldecott, K., Pappin, D. J. C., Yu, G.-L., Wang, R.-P., Shell, B. K., Nash, R. A., Schär, P., et al. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3206 · Cited by 260 · cited 1×
“6) and is comparable with the level detected in the testis, a tissue that is known to have high DNA ligase expression (30).”
BackgroundDifilippantonio, M. J., Petersen, S., Chen, H. T., Johnson, R., Jasin, M., Kanaar, R., Ried, T., & Nussenzweig, A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020851 · Cited by 227 · cited 1×
“NHEJ deficiency in the absence of p53 leads to rapid tumorigenesis in the developing lymphoid cells, due to the presence of unrepaired physiological DNA breaks in proliferating cells that lead to chromosomal translocation and oncogene activation (10,41).”
BackgroundUchida, T., Nakamura, T., Hashimoto, N., Matsuda, T., Kotani, K., Sakaue, H., Kido, Y., Hayashi, Y., Nakayama, K. I., White, M. F., et al. (2005) · Nature Medicine · doi:10.1038/nm1187 · Cited by 218 · cited 1×
“Overexpression of p16 (36) or p27 (37) leads to a decrease in -cell proliferation rate and reduction in -cell mass.”
BackgroundLymphocyte-Specific Compensation for XLF/Cernunnos End-Joining Functions in V(D)J Recombination
Li, G., Alt, F. W., Cheng, H.-L., Brush, J. W., Goff, P. H., Murphy, M. M., Franco, S., Zhang, Y., & Zha, S. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.07.017 · Cited by 194 · cited 2×
“Mice deficient for NHEJ factors other than Cernunnos/ XLF (4) develop severe combined immunodeficiency due to their failure to join DNA breaks generated during early lymphoid development in a DNA rearrangement process termed V(D)J recombination (5).”
BackgroundAnimal models of type 2 diabetes with reduced pancreatic β-cell mass
Masiello, P. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.09.007 · Cited by 187
Rad54 and DNA Ligase IV cooperate to maintain mammalian chromatid stability
Mills, K. D., Ferguson, D. O., Essers, J., Eckersdorff, M., Kanaar, R., & Alt, F. W. (2004) · Genes & Development · doi:10.1101/gad.1204304 · Cited by 135 · cited 2×
“The high expression level of DNA ligase IV in pancreatic islets led us to predict that DNA damage should accumulate in pancreatic islets of Lig4 / p53 mice (3).”
BackgroundHalvorsen, T., Beattie, G. M., Lopez, A., Hayek, A., & Levine, F. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1660103 · Cited by 133 · cited 1×
“Several reports have revealed that senescence induced by telomeric shortening or other means has been linked to limiting -cell proliferation and diabetes (21,22).”
BackgroundKukreja, A. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.12.4371 · Cited by 121 · cited 1×
“Type 1 diabetes results from the combined effects of genetic, environmental, and immunological factors that destroy pancreatic -cells (23).”
BackgroundFunctional pancreatic beta-cell mass: Involvement in type 2 diabetes and therapeutic intervention
Karaca, M., Magnan, C., & Kargar, C. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2008.09.007 · Cited by 114 · cited 1×
“Type 2 diabetes results from a progressive islet dysfunction leading to defective -cell secretion and insulin resistance (24,25).”
BackgroundDoes Damage to DNA and Other Macromolecules Play a Role in Aging? If So, How?
Campisi, J., & Vijg, J. (2009) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gln065 · Cited by 101
Cózar‐Castellano, I., Weinstock, M. T., Haught, M., Velázquez-García, S., Sipula, D., & Stewart, A. F. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0632 · Cited by 98 · cited 1×
“Although cell cycle inhibitor and p53 downstream target p21 is expressed in pancreatic -cells (39,40), islets grow and function normally in p21 deficiency, suggesting that other cell cycle inhibitors may function to compensate for the absence of p21.”
BackgroundZhang, X., Gaspard, J. P., Mizukami, Y., Li, J., Graeme‐Cook, F., & Chung, D. C. (2005) · Diabetes · doi:10.2337/diabetes.54.3.712 · Cited by 84 · cited 1×
“Conversely, overexpression of Cyclin D1 (35) or CDK4 (32) in the pancreas leads to hyperplasia of pancreatic islet cells, indicating the importance of these key molecules and highlighting the critical role of cell proliferation in the maintenance of -cells.”
BackgroundDNA damage-induced cellular senescence is sufficient to suppress tumorigenesis: a mouse model
Van Nguyen, T., Puebla-Osorio, N., Pang, H., Dujka, M. E., & Zhu, C. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062453 · Cited by 72 · cited 6×
“DNase-1–treated sections as positive controls (12).”
BackgroundSelf-citationRegulation of beta cell replication
Lee, Y. C., & Nielsen, J. H. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.08.033 · Cited by 63 · cited 2×
“highly regulated by intrinsic genetic programs, extrinsic growth factors, and hormone levels in response to various challenges and physiological demands (14,15).”
BackgroundAutophagy: A Sweet Process in Diabetes
Meijer, A. J., & Codogno, P. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.09.001 · Cited by 62 · cited 1×
“Regulation of -cell mass includes constant cell proliferation throughout life, although at different rates over time; continual cellular turnover is governed by the renewal and loss of -cells by mechanisms such as apoptosis (16).”
BackgroundRachdi, L., Balcazar, N., Elghazi, L., Barker, D. J., Krits, I., Kiyokawa, H., & Bernal-Mizrachi, E. (2006) · Diabetes · doi:10.2337/db06-0861 · Cited by 51 · cited 1×
“Conversely, p16 (36), p18, or p27 (38) deficiency results in pancreatic islet hyperplasia.”
BackgroundCozar-Castellano, I., Haught, M., & Stewart, A. F. (2006) · Diabetes · doi:10.2337/db06-0627 · Cited by 47
Huang, Y., Giblin, W., Kubec, M., Westfield, G., Charles, J. S., Chadde, L., Kraftson, S. J., & Sekiguchi, J. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20082396 · Cited by 45 · cited 2×
“The fac-tors involved in this conserved pathway are the DNA-dependent kinase complex (DNA-PKcs) and Ku heterodimer, the DNA ligase complex (DNA ligase IV, XRCC4, Cernunnos/XLF), and a DNA repair factor Artemis (2).”
BackgroundIslet dynamics: a glimpse at beta cell proliferation.
Yesil, P., & Lammert, E. (2008) · PubMed · doi:10.14670/hh-23.883 · Cited by 35
Puebla‐Osorio, N., & Zhu, C. (2008) · Immunologic Research · doi:10.1007/s12026-008-8015-3 · Cited by 31 · cited 1×
“Mice deficient for NHEJ factors other than Cernunnos/ XLF (4) develop severe combined immunodeficiency due to their failure to join DNA breaks generated during early lymphoid development in a DNA rearrangement process termed V(D)J recombination (5).”
BackgroundSelf-citationDiminished Pancreatic β-Cell Mass in Securin-Null Mice Is Caused by β-Cell Apoptosis and Senescence
Chesnokova, V., Wong, C., Zonis, S., Gruszka, A., Wawrowsky, K., Ren, S.-G., BenShlomo, A., & Yu, R. (2009) · Endocrinology · doi:10.1210/en.2008-0972 · Cited by 29 · cited 1×
“Interestingly, deficiency of PTTG leads to a progressive upregulation of p21 that drives pancreatic -cells into senescence that eventually results in insulinopenic diabetes (42).”
BackgroundNam, S. Y., Lee, M. K., & Sabapathy, K. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.142612 · Cited by 13 · cited 1×
“Although the p53 mutation prevents the induction of apoptosis, programmed cell death may occur independently of p53 expression (28).”
Background
Cited by
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity
Palmer, A. K., Tchkonia, T., LeBrasseur, N. K., Chini, E. N., Xu, M., & Kirkland, J. L. (2015) · Diabetes · doi:10.2337/db14-1820 · Cited by 423
“In mice lacking p53-dependent apoptosis, the burden of senescent cells increases rapidly and is associated with dysfunction of pancreatic b-cells, causing an overt diabetic phenotype in 3–4 months (65).”
BackgroundControl of metabolism by p53 – Cancer and beyond
Labuschagne, C. F., Zani, F., & Vousden, K. H. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.06.001 · Cited by 219
“While several studies suggest that the pathologies associated with p53 activation reflects enhanced activation of cell death, mice carrying a mutant p53 that has no apoptotic activity but retains cell cycle arrest function were also found to have a greater susceptibility to diabetes [135], suggesting a role for p53-in…”
BackgroundThe role of the p53 tumor suppressor in metabolism and diabetes
Kung, C.-P., & Murphy, M. E. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0324 · Cited by 178
NADPH oxidases: key modulators in aging and age-related cardiovascular diseases?
Sahoo, S., Meijles, D. N., & Pagano, P. J. (2016) · Clinical Science · doi:10.1042/cs20150087 · Cited by 146
“Finally, redox activation of p53/p21cip signalling leading to senescence is evident in murine models of hypertension [151,152], diabetes [153,154], atherosclerosis [155,156] and pulmonary hypertension [121,157].”
Background
Metadata
- Authors
- Tavana, O., Puebla-Osorio, N., Sang, M., & Zhu, C.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Department of Immunology, University of Texas, M.D. Anderson Cancer Center, Houston, Texas;
- Corresponding author
- Zhu, Chengming
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2009-10-15
- Volume
- 59
- Issue
- 1
- Pages
- 135-142
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2797914
- OpenAlex
- W2139190473
- Cited by
- 58
- References
- 43
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 3 · 2022: 4 · 2021: 7 · 2020: 3 · 2019: 5 · 2018: 3 · 2017: 4 · 2016: 6 · 2015: 2 · 2014: 1 · 2013: 2 · 2012: 1
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (CA-116933, R01CA116933)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- p53, DNA double-strand breaks, beta-cell mass, cellular senescence, p21, DNA damage, pancreatic islets, beta-cell proliferation, DNA repair, aging, lymphomagenesis
- MeSH terms
- DNA Ligase ATP, Insulin Secretion, Animals, Blood Glucose, Diabetes Mellitus, Experimental, DNA Damage, DNA-Binding Proteins, Immunity, Innate, Immunohistochemistry, Insulin, Islets of Langerhans, Mice, Inbred C57BL, Mice, Inbred Strains, Pancreas, Phenotype, DNA Ligases, Tumor Suppressor Protein p53, Cellular Senescence, Glucose Intolerance, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.